12/16/2025
This week on the Good Medicine Podcast, we are sharing a prerecorded panel hosted by Dr. David Bearss at the BioUtah Life Science Summit. The panel brings together leaders from across the industry, including Hariprasad Vankalapati of Biolexis, Alison O’Mahony of Seek Labs, and Ian Quigley of Leash Bio.
Together, they discuss how artificial intelligence is beginning to reshape drug discovery, diagnostics, and the way companies make decisions. The conversation highlights how AI helps teams understand both positive and negative data, identify emerging threats, and improve the success rate of bringing new drugs to market. This panel offers a grounded look at how AI is being used in real life science organizations today and what the future may hold.
This week on the Good Medicine Podcast, we are sharing a prerecorded panel hosted by Dr. David Bearss at the BioUtah Life Science Summit. The panel brings to...